Starbucks stock rating reaffirmed at Outperform by William Blair

Starbucks’ fiscal Q4 results beat expectations: comparable sales grew 7.2% versus 6% consensus, EPS was 11% above consensus, and adjusted operating margin expanded 460 basis points to 14%, its third consecutive quarter of recovery. North American comps rose 7.9%, while international comps slowed to 0.9% from 5.7% in Q3; reported EPS was $0.80 versus $0.71 expected, but revenue of $9.1 billion missed the $9.22 billion forecast. William Blair reiterated Outperform, though InvestingPro’s Fair Value analysis characterized the shares as overvalued at a P/E of 60.14.

Analysis

The key change is that SBUX is being judged less on cost recovery and more on whether it can convert stronger U.S. demand into sustained revenue growth. Broad domestic comps make the recovery more credible than a narrow premium-customer rebound, but the revenue miss and international traffic decline are important quality checks: ticket-led growth can fade if traffic does not stabilize. Margin expansion can support near-term EPS even while top-line delivery remains imperfect; it should not be extrapolated without evidence that operating improvements persist as the company invests in its growth plan.

Near term, the earnings beat may support sentiment, but the valuation cited in the article leaves limited room for execution slippage. Over the next 1–3 months, watch U.S. traffic and ticket separately, international traffic, and whether revenue guidance catches up with earnings momentum. Over 6–18 months, durable gains depend on retaining customers while improving service and store economics—not simply repeating cost leverage. Competitors could benefit if Starbucks’ service or value proposition weakens, but this is not yet evidence of share loss.

Contrarian read: the international slowdown may be partly comparison-driven, so it is premature to treat it as a broad demand break; conversely, the headline comp and EPS beats may overstate underlying acceleration given the sales shortfall. No clean directional edge without price action and guidance detail.

Key Decisions for Investors

• Do not chase the post-earnings strength solely on the EPS beat. Consider a staged SBUX entry only if the stock holds its post-earnings low and subsequent updates confirm U.S. traffic is not deteriorating; that low is the near-term thesis-failure level.
• For existing holders, retain exposure but avoid adding aggressively at a valuation that demands continued execution. Reassess if revenue guidance remains weak while EPS growth relies primarily on margin recovery.
• Track the next results for comparable-sales composition—traffic versus ticket—by North America and international markets, plus operating margin and sales guidance. Broad-based U.S. traffic growth would strengthen the long thesis; further international traffic contraction or a reversal in margin gains would weaken it.
• No options trade is warranted from the supplied information: current share price, implied volatility, and post-earnings positioning are missing. Revisit only after checking those inputs and the stock’s reaction relative to consumer and restaurant peers.